Literature DB >> 24880684

Dominance of clonal complex 10 among the levofloxacin-resistant Streptococcus agalactiae isolated from bacteremic patients in a Korean hospital.

Hyejin Ryu1, Yeon-Joon Park2, Yong-Kyun Kim3, Jiyoung Chang1, Jin Kyung Yu1.   

Abstract

Streptococcus agalactiae has emerged as an important cause of invasive infection in adults. Forty-nine S. agalactiae isolates (41 from adults and 8 from neonates) were collected during a 4-year period (2010-2013) and analyzed by multilocus sequence typing (MLST). Antibiotic susceptibility to erythromycin, clindamycin and levofloxacin was determined and the determinants of resistance (ermA, ermB, ermC, mefA, lnuB) were detected by PCR and mutation in gyrA, gyrB, parC and parE gene was investigated by sequence analysis. They were resolved into 14 sequence types (STs) and belonged to five clonal complexes (CCs). The distribution of CC was significantly different according to the age group; CC1 (18/41) and CC10 (13/41) was the most common among the adult isolates but CC19 (5/8) was predominant among the neonatal isolates. The resistance rate to erythromycin, clindamycin was 18.4% and 24.5%, respectively. Among the 13 strains resistant to erythromycin and/or clindamycin, two isolates harbored ermA and 10 isolates harbored ermB. The levofloxacin resistance rate was very high (32.7%) and was significantly higher in CC10 (71.4%). All the levofloxacin-resistant isolates had identical gyrA substitution (Ser81Leu) but parC substitution was different according to the CCs. The additional mutation in parE (His221Tyr) was found only in CC19. Continuous monitoring of the fluoroquinolone resistance and genotypic distribution among S. agalactiae is needed.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Multilocus sequence typing; parC; parE

Mesh:

Substances:

Year:  2014        PMID: 24880684     DOI: 10.1016/j.jiac.2014.03.005

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  6 in total

1.  Changing Epidemiology of Group B Streptococcus Susceptibility to Fluoroquinolones and Aminoglycosides in France.

Authors:  Constantin Hays; Mathilde Louis; Céline Plainvert; Nicolas Dmytruk; Gérald Touak; Patrick Trieu-Cuot; Claire Poyart; Asmaa Tazi
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

2.  Molecular Characteristics of Group B Streptococci Isolated from Adults with Invasive Infections in Japan.

Authors:  Miyuki Morozumi; Takeaki Wajima; Misako Takata; Satoshi Iwata; Kimiko Ubukata
Journal:  J Clin Microbiol       Date:  2016-08-24       Impact factor: 5.948

3.  DNA microarray-based typing of Streptococcus agalactiae isolates.

Authors:  Heike Nitschke; Peter Slickers; Elke Müller; Ralf Ehricht; Stefan Monecke
Journal:  J Clin Microbiol       Date:  2014-08-27       Impact factor: 5.948

4.  Clonal Distribution of Clindamycin-Resistant Erythromycin-Susceptible (CRES) Streptococcus agalactiae in Korea Based on Whole Genome Sequences.

Authors:  Takashi Takahashi; Takahiro Maeda; Seungjun Lee; Dong-Hyun Lee; Sunjoo Kim
Journal:  Ann Lab Med       Date:  2020-09       Impact factor: 3.464

5.  Clinical characteristics and molecular epidemiology of invasive Streptococcus agalactiae infections between 2007 and 2016 in Nara, Japan.

Authors:  Nobuyasu Hirai; Kei Kasahara; Ryuichi Nakano; Yoshihiko Ogawa; Yuki Suzuki; Miho Ogawa; Naokuni Hishiya; Akiyo Nakano; Sadahiro Ichimura; Hisakazu Yano; Masahide Yoshikawa
Journal:  PLoS One       Date:  2020-10-19       Impact factor: 3.240

Review 6.  Endogenous endophthalmitis caused by group B streptococcus; case reports and review of 35 reported cases.

Authors:  Masaaki Yoshida; Shunji Yokokura; Takashi Nishida; Kiyofumi Mochizuki; Takashi Suzuki; Kazuichi Maruyama; Takaaki Otomo; Koji M Nishiguchi; Hiroshi Kunikata; Toru Nakazawa
Journal:  BMC Ophthalmol       Date:  2020-03-31       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.